이권선

All filings by 이권선 on record concern 셀바이오휴먼텍, in the capacity of chief executive. The record holds 38 filings, for trades running from 20 April 2023 to 12 June 2026.

Every open-market trade on record is a purchase: 38 purchases worth €63k, and no sale. The totals exclude 35 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 8 purchases and no sales.

In size, the median ticket on the buying side is €22k. Scaled by market value, the purchases weigh a median 0.072% of market cap (sample: 3 purchases). No cluster: in 28 purchases, no other insider of the company bought within 30 days. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -17.1%. Past outcomes like these are no guarantee of what comes next.

The newest entry dates from 12 June 2026: an open-market purchase, in 셀바이오휴먼텍. The median gap between a trade and its publication by DART (FSS) is 5 days. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.